Last reviewed · How we verify

NCT05723380

Prediction of Clinical Outcome in Thoracic ESPB

Completed Last updated 7 October 2025
What this trial tests

trial testing Erector spinae plane block in Pain, Chronic in 92 participants. Completed in 30 November 2023.

Timeline
13 February 2023
Primary endpoint
30 November 2023
30 November 2023

Quick facts

Lead sponsorKeimyung University Dongsan Medical Center
StatusCompleted
Study typeOBSERVATIONAL
Enrollment92
Start date13 February 2023
Primary completion30 November 2023
Estimated completion30 November 2023
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Keimyung University Dongsan Medical Center

Who can join

Adults 20 to 80, any sex, with Pain, Chronic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary endpoint of this study was to identify that Perfusion index (PI) has any predictive value for the treatment outcome of cervical radiculopathy

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Erector spinae plane block

Trials testing the same drug.

Other recruiting trials for Pain, Chronic

Currently open trials in the same condition.

Other Keimyung University Dongsan Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05723380.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing